Emmanuel Mbuba

Mr. Emmanuel Mbuba


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EMEmmanuel Mbuba
Emmanuel Mbuba
OOOlukayode Ganiu Odufuwa
Olukayode Ganiu Odufuwa
JMJason Moore
Jason Moore
SMSelemani Mmbaga
Selemani Mmbaga
ETEmile Tchicaya
Emile Tchicaya
Sarah J MooreSarah J Moore
Sarah J Moore
Background: Mass distributions of long-lasting insecticidal nets (LLINs) have contributed to large reductions in the malaria burden. However, this success is in jeopardy due in part to the increasing pyrethroid-resistant mosquito population as well as low LLINs coverage in various areas because the lifespan of LLINs is often shorter than the interval between replenishment campaigns. New insecticide-treated nets (ITNs) containing pyrethroid and piperonyl-butoxide (PBO) have shown a greater reduction in the incidence of malaria than pyrethroid LLINs in areas with pyrethroid-resistant mosquitoes. However, the durability (attrition, bio-efficacy, physical integrity and chemical retainment) of pyrethroid-PBO ITNs under operational settings has not been fully characterized. This study will measure the durability of pyrethroid-PBO ITNs to assess whether they meet the World Health Organization (WHO) three years of operational performance criteria required to be categorized as “long-lasting”. Methods: A prospective household randomized controlled trial will be conducted simultaneously in Tanzania, India and Côte d’Ivoire to estimate the field durability of three pyrethroid-PBO ITNs (Veeralin®, Tsara® Boost, and Olyset® Plus) compared to a pyrethroid LLIN: MAGNet®. Durability monitoring will be conducted up to 36 months post-distribution and median survival in months will be calculated. The proportion of ITNs: (1) lost (attrition), (2) physical integrity, (3) resistance to damage score, (4) meeting WHO bio-efficacy (≥ 95% knockdown after 1 h or ≥ 80% mortality after 24 h for WHO cone bioassay, or ≥ 90% blood-feeding inhibition or ≥ 80% mortality after 24 h for WHO Tunnel tests) criteria against laboratory-reared resistant and susceptible mosquitoes, and insecticidal persistence over time will be estimated. The non-inferiority of Veeralin® and Tsara® Boost to the first-in-class, Olyset® Plus will additionally be assessed for mortality, and the equivalence of 20 times washed ITNs compared to field aged ITNs will be assessed for mortality and blood-feeding inhibition endpoints in the Ifakara Ambient Chamber Test, Tanzania. Conclusion: This will be the first large-scale prospective household randomized controlled trial of pyrethroid-PBO ITNs in three different countries in East Africa, West Africa and South Asia, simultaneously. The study will generate information on the replenishment intervals for PBO nets.

6 January 2021 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EMEmmanuel Mbuba
Emmanuel Mbuba
OOOlukayode G. Odufuwa
Olukayode G. Odufuwa
FTFrank C. Tenywa
Frank C. Tenywa
RPRose Philipo
Rose Philipo
MTMgeni M. Tambwe
Mgeni M. Tambwe
Sarah J MooreSarah J Moore
Sarah J Moore
Background: N,N-Diethyl-3-methylbenzamide (DEET) topical mosquito repellents are effective personal protection tools. However, DEET-based repellents tend to have low consumer acceptability because they are cosmetically unappealing. More attractive formulations are needed to encourage regular user compliance. This study evaluated the protective efficacy and protection duration of a new topical repellent ointment containing 15% DEET, MAÏA® compared to 20% DEET in ethanol using malaria and dengue mosquito vectors in Bagamoyo Tanzania. Methods: Fully balanced 3 × 3 Latin square design studies were conducted in large semi-field chambers using laboratory strains of Anopheles gambiae sensu stricto, Anopheles arabiensis and Aedes aegypti. Human volunteers applied either MAÏA® ointment, 20% DEET or ethanol to their lower limbs 6 h before the start of tests. Approximately 100 mosquitoes per strain per replicate were released inside each chamber, with 25 mosquitoes released at regular intervals during the collection period to maintain adequate biting pressure throughout the test. Volunteers recaptured mosquitoes landing on their lower limbs for 6 h over a period of 6 to 12-h post-application of repellents. Data analysis was conducted using mixed-effects logistic regression. Results: The protective efficacy of MAÏA® and 20% DEET was not statistically different for each of the mosquito strains: 95.9% vs. 97.4% against An. gambiae (OR = 1.53 [95% CI 0.93–2.51] p = 0.091); 96.8% vs 97.2% against An. arabiensis (OR = 1.08 [95% CI 0.66–1.77] p = 0.757); 93.1% vs 94.6% against Ae. aegypti (OR = 0.76 [95% CI 0.20–2.80] p = 0.675). Average complete protection time (CPT) in minutes of MAÏA® and that of DEET was similar for each of the mosquito strains: 571.6 min (95% CI 558.3–584.8) vs 575.0 min (95% CI 562.1–587.9) against An. gambiae; 585.6 min (95% CI 571.4–599.8) vs 580.9 min (95% CI 571.1–590.7) against An. arabiensis; 444.1 min (95% CI 401.8–486.5) vs 436.9 min (95% CI 405.2–468.5) against Ae. aegypti. Conclusions: MAÏA® repellent ointment provides complete protection for 9 h against both An. gambiae and An. arabiensis, and 7 h against Ae. aegypti similar to 20% DEET (in ethanol). MAÏA® repellent ointment can be recommended as a tool for prevention against outdoor biting mosquitoes in tropical locations where the majority of the people spend an ample time outdoor before going to bed.

21 June 2022 in Insects
Verified
Journal Article
Open access
PDF file
DKDismas Simwela Kamande
Dismas Simwela Kamande
OOOlukayode Ganiu Odufuwa
Olukayode Ganiu Odufuwa
EMEmmanuel Mbuba
Emmanuel Mbuba
LHLorenz Hofer
Lorenz Hofer
Sarah J MooreSarah J Moore
Sarah J Moore
The standard World Health Organization (WHO) tunnel test is a reliable laboratory bioassay used for “free-flying” testing of insecticide-treated nets (ITNs) bio-efficacy where mosquitoes pass through a ITN sample to reach a live animal bait. Multiple parameters (i.e., bait, exposure time, and mosquito density) may affect the outcomes measured in tunnel tests. Therefore, a comparison was conducted of alternative hosts, exposure time, and lower mosquito density against the current gold standard test (100 mosquitoes, animal bait, and 12-h exposure) as outlined in the WHO ITN evaluation guideline. This was done with the aim to make the tunnel test cheaper and with higher throughput to meet the large sample sizes needed for bio-efficacy durability monitoring of chlorfenapyr ITNs that must be evaluated in “free-flying” bioassays. Methods: A series of experiments were conducted in the WHO tunnel test to evaluate the impact of the following factors on bio-efficacy endpoints of mosquito mortality at 24-h (M24) and 72-h (M72) and blood-feeding success (BFS): (1) baits (rabbit, membrane, human arm); (2) exposure time in the tunnel (1 h vs. 12 h); and (3) mosquito density (50 vs. 100). Finally, an alternative bioassay using a membrane with 50 mosquitoes (membrane-50) was compared to the gold standard bioassay (rabbit with 100 mosquitoes, rabbit-100). Pyrethroid-resistant Anopheles arabiensis and pyrethroid susceptible Anopheles gambiae were used to evaluate Interceptor® and Interceptor® G2 ITNs. Results: Using a human arm as bait gave a very different BFS, which impacted measurements of M24 and M72. The same trends in M24, M72 and BFS were observed for both Interceptor® ITN and Interceptor® G2 unwashed and washed 20 times measured using the gold standard WHO tunnel test (rabbit-100) or rabbit with 50 mosquitoes (rabbit-50). M24, M72 and BFS were not statistically different when either 50 or 100 mosquitoes were used with rabbit bait in the tunnel bioassay for either the susceptible or resistant strains. No systematic difference was observed between rabbit-50 and rabbit-100 in the agreement by the Bland and Altman method (B&A). The mean difference was 4.54% (−22.54–31.62) in BFS and 1.71% (−28.71–32.12) in M72 for rabbit-50 versus rabbit-100. Similar M24, M72 and lower BFS was measured by membrane-50 compared to rabbit-100. No systematic difference was observed in the agreement between membrane-50 and rabbit-100, by B&A. The mean difference was 9.06% (−11.42–29.64) for BSF and −5.44% (−50.3–39.45) for M72. Both membrane-50, rabbit-50 and rabbit-100 predicted the superiority of Interceptor® G2 over Interceptor® ITN for the resistant strain on M72. Conclusion: These results demonstrate that WHO tunnel tests using rabbit bait may be run with 50 mosquitoes to increase sample sizes needed for bio-efficacy durability monitoring of ITNs in “free-flying” bioassays. Using a membrane feeder with 50 mosquitoes is a potential replacement for the WHO tunnel bioassay with animal bait if control blood feeding rates can be improved to 50% because blood feeding impacts mosquito survival after exposure to insecticides.

24 December 2024 in Frontiers in Malaria
Verified
Journal Article
Open access
PDF file
JMJane Johnson Machange
Jane Johnson Machange
EMEmmanuel Mbuba
Emmanuel Mbuba
SISeth R. Irish
Seth R. Irish
JSJohnson Kyeba Swai
Johnson Kyeba Swai
WNWatson Ntabaliba
Watson Ntabaliba
SMSarah Jane Moore
Sarah Jane Moore
Introduction: The resistance of malaria vectors to pyrethroids has compromised the efficacy of pyrethroid insecticide-treated nets (ITNs). In response, ITNs with pyrethroids and piperonyl butoxide (PBO) synergists were developed to overcome metabolic pyrethroid resistance mechanisms. One such net is Vector Guard®. To demonstrate its potential efficacy for public health use, a comparative efficacy study was conducted to evaluate Vector Guard® relative to Olyset® Plus (a pyrethroid–PBO ITN proven to reduce malaria transmission more effectively than pyrethroid ITNs) and Royal® Sentry 2.0 (a pyrethroid-only ITN included to demonstrate the added benefit of PBO) in experimental huts in Tanzania.Methods: An experimental hut trial using two blocks of a 7 × 7 Latin square design was conducted over seven rounds (49 experimental nights). Treatments were rotated at the end of each round, and volunteers were rotated nightly within one block. Both unwashed and 20× washed nets of each type were evaluated, alongside an untreated net used as a negative control. The primary endpoint was the proportion of Anopheles arabiensis that died within 24 h, and the secondary endpoint was the proportion of blood feeding. Data were analyzed using binomial logistic regression with fixed effects using a 7% non-inferiority margin.Results: The pooled results showed that Vector Guard® was non-inferior and was superior to Olyset® Plus, with higher mortality for Vector Guard® [28% vs. 18%; odds ratio (OR) = 1.93, 95%CI = 1.81–2.06]. Both pyrethroid–PBO nets were superior to Royal Sentry® 2.0 (p < 0.001) in terms of mosquito mortality. For the secondary blood feeding endpoint, Vector Guard® was also found to be non-inferior to Olyset® Plus (0.6% vs. 0.2%; OR = 2.37, 95%CI = 1.77–3.17). Vector Guard® showed similar efficacy to Royal Sentry® 2.0 in reducing the proportion of mosquito blood feeding (0.6% vs. 0.6%; OR = 0.85, 95%CI = 0.68–1.07, p = 0.161).Conclusion: Vector Guard® demonstrated superior mosquito mortality compared with both Olyset® Plus and Royal Sentry® 2.0, indicating that Vector Guard® is another promising pyrethroid–PBO ITN for the control of resistant malaria vectors. The addition of Vector Guard® to the class of pyrethroid–PBO ITNs will enable malaria control programs to select cost-effective ITNs, improving access to effective protection from malaria transmitted by resistant vectors.

22 August 2022 in Research Square
Verified
Preprint
Open access
PDF file
EMEmmanuel Mbuba
Emmanuel Mbuba
OOOlukayode G. Odufuwa
Olukayode G. Odufuwa
JMJason Moore
Jason Moore
SMSelemani Mmbaga
Selemani Mmbaga
ETEmile Tchicaya
Emile Tchicaya
SMSarah J. Moore
Sarah J. Moore
Background Mass distributions of long-lasting insecticidal nets (LLINs) has contributed to large reductions in the malaria burden. However, this success is in jeopardy due in part to the increasing pyrethroid-resistant mosquito population as well as low LLINs coverage in various areas because the lifespan of LLINs is often shorter than the interval between replenishment campaigns. New insecticide-treated nets (ITNs) containing pyrethroid and piperonyl-butoxide (PBO) have shown a greater reduction in the incidence of malaria than pyrethroid LLINs in areas with pyrethroid-resistant mosquitoes. However, the durability of pyrethroid-PBO ITNs under operational settings is not fully characterized. This study will measure the bioefficacy and physical durability of pyrethroid-PBO ITNs over three years to assess whether they meet the World Health Organisation (WHO) three years operational performance criteria required to be categorised as “long-lasting”. Methods A prospective household randomized controlled trial will be conducted simultaneously in Tanzania, India and Côte d’Ivoire to estimate the field durability of three pyrethroid-PBO ITNs (Veeralin®, Tsara® Boost, and Olyset® Plus) compared to a pyrethroid LLIN: MAGNet®. Durability monitoring will be conducted up to 36 months post-distribution and median survival in months will be calculated. The proportion of ITNs lost (attrition), the physical integrity of the nets, resistance to damage score, the proportion of ITNs meeting WHO bioefficacy criteria against laboratory-reared resistant and susceptible mosquitoes, and insecticidal persistence over time will be estimated. The non-inferiority of Veeralin® and Tsara® Boost to the first-in-class, Olyset® Plus will be assessed for mortality, and the equivalence of 20 times washed ITNs compared to field aged ITNs will be assessed for mortality and blood-feeding inhibition endpoints in the Ifakara Ambient Chamber Test, Tanzania. Discussion This will be the first large-scale prospective household randomised controlled trial of pyrethroid-PBO ITNs in three different countries representing East Africa, West Africa and South Asia region simultaneously. The study findings will generate information on average replenishment intervals for PBO nets.

4 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
OOOlukayode Ganiu Odufuwa
Olukayode Ganiu Odufuwa
RSRichard J. Sheppard
Richard J. Sheppard
SNSafina Ngonyani
Safina Ngonyani
AMAhmadi Bakari Mpelepele
Ahmadi Bakari Mpelepele
DKDickson Kobe
Dickson Kobe
Sarah J MooreSarah J Moore
Sarah J Moore
Background: Despite extensive use of available vector control tools, the burden of malaria and dengue continues to increase throughout sub-Saharan Africa. Gaps in house structures, most especially in eaves and windows, allow vector entry and facilitate indoor vector biting and disease burden. Simple house modification tools that target these structures therefore have the potential to reduce human exposure to bites in the home. This study assessed the performance of Insecticide Treated Screening (ITS) comprising Eave Nets and Window Screens (ITENs & ITWS), incorporated with deltamethrin and piperonyl-butoxide (PBO) in Tanzania. Method: A randomised Latin square (4 X 4) was conducted in four experimental huts built in a semi-field system (SFS). Each hut within each of the chambers of the SFS was covered with a large netting cage to allow recapture of mosquitoes inside and outside of the huts. Four treatment arms were evaluated: 1) new ITS; 2) 12-months naturally-aged ITS; 3) estimated 12 months field-used Olyset® Plus ITNs (Standard-of-Care in Tanzania), and; 4) no treatment. The study was performed for 32 nights using a minimum of 30 mosquitoes per strain per night, that is, a total of 120 (4 x 30) mosquitoes per hut per night. Four laboratory-reared strains were used: transmitters of malaria ( Anopheles arabiensis and An. funestus ) and dengue infection ( Aedes aegypti ) and those known for nuisance biting ( Culex quinquefasciatus ). Recaptured mosquitoes were assessed for mortality at 72 hours (M72), blood feeding and hut entry endpoints. A simulation exercise with a modified mechanistic model tracking Plasmodium falciparum malaria was used to illustrate the potential epidemiological impact from these products. Results: New ITS induced higher M72 than field-used ITNs against all mosquito species tested [OR: 2.25 (95%CI: 1.65-3.06), p<0.0001], while M72 was similar between aged ITS and field-used ITNs [OR: 0.80 (95%CI: 0.59-1.08), p=0.141]. Both new, and aged ITS reduced more mosquito blood feeding and hut entry than field-used ITNs for all mosquito species tested (p<0.0001). Transmission model estimates indicate epidemiological impacts of ITS may supersede those of ITNs at the population level. The model results indicate that the potency of these impacts depends on assumed intervention percentage cover, durability and mosquito bionomics. Conclusions: ITS is an efficacious tool for controlling vectors transmitting malaria, and dengue, and those known for nuisance biting in a semi-field setting. Given the intervention’s simplicity, it should be considered as an additional (or stand-alone) tool alongside behavioural change educational efforts to encourage the repurposing of old ITNs for house screening.